Literature DB >> 1530124

Molecular and cellular biology of Fanconi anemia.

C A Strathdee1, M Buchwald.   

Abstract

Fanconi anemia (FA) is an autosomal recessive disorder characterized by progressive pancytopaenia, a diverse assortment of congenital malformations, and a predisposition to the development of malignancies. The extensive clinical heterogeneity observed in FA is reflected in genetic heterogeneity; the existence of 4 complementation groups has been inferred from complementation analysis. FA is putatively characterized as a DNA repair disorder since cells derived from patients are hypersensitive to DNA cross-linking agents. Although the primary defects in FA are not known, biochemical evidence supports either a direct defect in the removal of DNA cross-links or a defect in the ability of cells to respond to oxidative stress resulting from the interaction with cross-linking agents. Confirmation of either hypothesis awaits the cloning of genes defective in FA; some of the strategies to this end are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1530124     DOI: 10.1097/00043426-199205000-00015

Source DB:  PubMed          Journal:  Am J Pediatr Hematol Oncol        ISSN: 0192-8562


  4 in total

1.  Cloning of the bovine and rat Fanconi anemia group C cDNA.

Authors:  J Ching Ying Wong; N Alon; M Buchwald
Journal:  Mamm Genome       Date:  1997-07       Impact factor: 2.957

2.  The Fanconi anemia polypeptide FACC is localized to the cytoplasm.

Authors:  T Yamashita; D L Barber; Y Zhu; N Wu; A D D'Andrea
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

3.  Fanconi anemia complementation group A cells are hypersensitive to chromium(VI)-induced toxicity.

Authors:  Susan K Vilcheck; Travis J O'Brien; Daryl E Pritchard; Linan Ha; Susan Ceryak; Jamie L Fornsaglio; Steven R Patierno
Journal:  Environ Health Perspect       Date:  2002-10       Impact factor: 9.031

4.  A Case of Hypopharyngeal Cancer Associated With Fanconi Anemia: A Helical Tomotherapy Experience.

Authors:  Gizem Kavak; Semih Basci; Esra Türker Kekilli; Mehmet S Dal; Ebru Karakaya
Journal:  Cureus       Date:  2021-11-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.